|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Seattle Genetics’ Market Debut, Pathway Gets Bought, Theraclone’s Latest Trick Against HIV, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/25/11 |
Seattle
|
|
Scientists Spot New Antibodies Against HIV, Opening Up Potential Path to AIDS Vaccine
|
Luke Timmerman |
08/17/11 |
National
|
|
iAMscientist, Backed by George Whitesides, Tries to Help Firms and Institutes Find Top Talent
|
Gregory T. Huang |
02/23/11 |
Boston
|
|
Theraclone Raises $1.5M
|
Luke Timmerman |
03/19/10 |
Seattle
|
|
Targeted Genetics Lives On, CellCyte Charged With Fraud, Theraclone Finds HIV Weakness, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
09/10/09 |
Seattle
|
|
Finding HIV’s Weak Spot, Scientists at Seattle’s Theraclone and San Diego’s Scripps See Opening for New Vaccine
|
Luke Timmerman |
09/03/09 |
National
|
|
Inovio, Fueled By Swine Flu Fear, Comes Back From Brink With ‘Universal’ Vaccines
|
Luke Timmerman |
08/25/09 |
San Diego
|
|
Targeted Genetics Dumps Lease, Amgen’s Dmab Works in Cancer Trial, Theraclone Nabs Cash, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
07/09/09 |
Seattle
|
|
Theraclone Gets Funding for HIV
|
Luke Timmerman |
07/06/09 |
Seattle
|
|
Theraclone Sciences Garners New Financing
|
VentureDeal |
07/06/09 |
Seattle
|
|
Antibodies for HIV, Long Dismissed, Show Signs of Comeback at Seattle’s Theraclone
|
Luke Timmerman |
04/07/09 |
Seattle
|
|
PATH, Fueled by Bill Gates’ Fortune, Builds Global Health Hothouse in Seattle
|
Luke Timmerman |
02/04/09 |
Seattle
|
|
Scripps, IAVI to Establish $30 Million AIDS Vaccine Research Center
|
Luke Timmerman |
10/01/08 |
San Diego
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.
